| Financial Year |
March 31 2023 |
| Monetary Funds |
907,370,252.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,117,086,761.08 |
| Advances to Suppliers |
1,566,228.31 |
| Other Receivables |
12,768,539.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
74,928,129.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
306,426,035.36 |
| Total Current Assets |
2,451,790,495.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,031,583.26 |
| Investment Properties |
-- |
| Fixed Assetes |
12,494,372,314.79 |
| Under-construction Projects |
3,035,045,001.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,355,219,588.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,483,617.36 |
| Deferred Income Tax Assets |
140,017,409.31 |
| Other Non-Current Assets |
143,617,763.56 |
| Sub-Total of Non-Current Assets |
17,205,530,203.88 |
| Total Assets |
19,657,320,699.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,321,961,009.88 |
| Accounts Received In Advance |
51,156,890.13 |
| Employee Compensation Payable |
68,332,726.55 |
| Taxes Payable |
19,327,211.26 |
| Interest Payable |
-- |
| Dividend Payable |
2,950,678.63 |
| Other payables |
127,664,923.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,522,137,682.66 |
| Other Current Liabilities |
7,203,956.58 |
| Sub-Total of Current Liabilities |
4,179,973,471.89 |
| Long-term Loans |
8,316,412,914.37 |
| Bonds Payable |
1,638,990,333.41 |
| Long-Term Accounts Payable |
295,297,642.51 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,794,338,301.53 |
| Total Liabilities |
14,974,311,773.42 |
| Paid-In Capital(Or Share Stock) |
882,973,077.00 |
| Capital Surplus |
1,521,133,690.09 |
| Surplus Reserve |
331,205,583.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,947,696,575.61 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,683,008,926.27 |
| Owner's Equity（Stockholder's Equity） |
4,683,008,926.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,657,320,699.69 |
